SeaCrest Wealth Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.87K | Hold |
13,000
| – | – | ﹤0.01% | 617 |
|
|
2025
Q1 | $11.8K | Hold |
13,000
| – | – | ﹤0.01% | 655 |
|
|
2024
Q4 | $14.2K | Hold |
13,000
| – | – | ﹤0.01% | 653 |
|
|
2024
Q3 | $9.84K | Hold |
13,000
| – | – | ﹤0.01% | 649 |
|
|
2024
Q2 | $16.1K | Hold |
13,000
| – | – | ﹤0.01% | 612 |
|
|
2024
Q1 | $24.6K | Sell |
13,000
-1,000
| -7% | -$1.89K | ﹤0.01% | 600 |
|
|
2023
Q4 | $36.7K | Hold |
14,000
| – | – | ﹤0.01% | 615 |
|
|
2023
Q3 | $32.2K | Hold |
14,000
| – | – | ﹤0.01% | 617 |
|
|
2023
Q2 | $51.1K | Hold |
14,000
| – | – | 0.01% | 619 |
|
|
2023
Q1 | $50K | Hold |
14,000
| – | – | 0.01% | 617 |
|
|
2022
Q4 | $39.9K | Sell |
14,000
-2,000
| -13% | -$5.7K | 0.01% | 622 |
|
|
2022
Q3 | $36K | Hold |
16,000
| – | – | 0.01% | 615 |
|
|
2022
Q2 | $40K | Hold |
16,000
| – | – | 0.01% | 1213 |
|
|
2022
Q1 | $78K | Hold |
16,000
| – | – | 0.01% | 700 |
|
|
2021
Q4 | $181K | Sell |
16,000
-4,000
| -20% | -$45.3K | 0.02% | 664 |
|
|
2021
Q3 | $291K | Hold |
20,000
| – | – | 0.04% | 498 |
|
|
2021
Q2 | $233K | Hold |
20,000
| – | – | 0.03% | 586 |
|
|
2021
Q1 | $244K | Hold |
20,000
| – | – | 0.03% | 531 |
|
|
2020
Q4 | $250K | Buy |
+20,000
| New | +$250K | 0.04% | 490 |
|